ALNYLAM PHARMACEUTICALS INC
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for ALNYLAM PHARMACEUTICALS INC NOTE 1.000% 9/1, CUSIP 02043QAB3.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for ALNYLAM PHARMACEUTICALS INC NOTE 1.000% 9/1, CUSIP 02043QAB3.